Caregiver-Reported Barriers and Facilitators to Deprescribing in Older Adults With Dementia: A Systematic Review
Tara Klinedinst, Sarah Joseph, Te-Lien Ku, April Schweikhard, Beth Fields, Lee Jennings

TL;DR
This paper reviews barriers and facilitators to deprescribing in older adults with dementia as reported by caregivers, highlighting the need for better communication and support.
Contribution
The study systematically identifies caregiver-reported factors influencing deprescribing decisions in dementia care.
Findings
Barriers include limited caregiver knowledge, fear of giving up treatment, and poor provider collaboration.
Facilitators include trusting provider relationships and proactive communication about deprescribing.
Caregiver confidence in deprescribing is influenced by communication, trust, and medication side effects.
Abstract
Many older adults with ADRD are at heightened risk for inappropriate medication prescription, due to the complexity of managing dementia in addition to comorbid medical conditions. Deprescribing medications that are harmful or no longer beneficial can prevent illness and injury, and caregivers play a crucial role in this process. Unfortunately, guidance on decision-making and practical supports for caregivers interested in deprescribing is limited. Previous low-touch interventions have not significantly reduced prescriptions, indicating that older adults with ADRD and their caregivers may need more intensive supports and resources during the deprescribing process. To address this gap, we used systematic review methodology to characterize barriers and facilitators to deprescribing as reported by caregivers of older adults with ADRD. We used thematic analysis to synthesize qualitative…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsDementia and Cognitive Impairment Research · Pharmaceutical Practices and Patient Outcomes · Medication Adherence and Compliance
